Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate

14 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

710.0%

Death Rate

Active Ingredients

Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate

Administration Routes

UnknownOphthalmicTopicalIntraocular

Species Affected

Dog 14

Most Affected Breeds

Maltese 4

Crossbred Canine/dog 3

Poodle - Miniature 1

Shiba Inu 1

Retriever - Labrador 1

Terrier - West Highland White 1

Shih Tzu 1

Bulldog - English 1

Boxer (German Boxer) 1

Most Reported Reactions

Decreased appetite 3

Crust 3

Erythema (for urticaria see Immune SOC) 3

Lack of efficacy (endoparasite) - hookworm 3

Deafness 2

Elevated serum alkaline phosphatase (SAP) 2

Elevated alanine aminotransferase (ALT) 2

Elevated gamma-glutamyl transferase (GGT) 2

Local swelling (not application site) 2

Hyperpigmentation 2

Pinnae disorder 2

Loose stool 2

Outcome Breakdown

Outcome Unknown

8 (57.1%)

Ongoing

3 (21.4%)

Recovered with Sequela

1 (7.1%)

Recovered/Normal

1 (7.1%)

Died

1 (7.1%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.